Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
GlaxoSmithKline Bio
New malaria vaccine has promising test results
November 6th, 2004
Scientists have made important progress in the quest for a malaria vaccine, showing for the first time that childhood shots can prevent nearly one-third of cases and slash the risk of severe, life-threatening attacks by almost two-thirds. Experts said the findings, outlined the Lancet medical journal, provide robust evidence that the dream of developing a vaccine that will get babies through the most vulnerable period of infancy could become a reality by the end of the decade. Researchers have been working on a malaria vaccine for more than 20 years, but until now none of the candidates showed promise. If this research bears fruit, it would be...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2004-11-06)
|
